Skip to content

Laser therapy in treatment of Trigger Finger and De Quervains

Laser therapy in treatment of Trigger Finger and De Quervains: a randomised control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN85358156
Enrollment
90
Registered
2013-04-12
Start date
2013-06-01
Completion date
Unknown
Last updated
2017-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger finger disease, De Quervains tenosynovitis Musculoskeletal Diseases Trigger finger, Radial styloid tenosynovitis [de Quervain]

Interventions

There are 3 groups in this study: 1. Trigger finger in non-diabetics: 1.1. 15 patients treated with Laser therapy 1.2. 15 patients treated with splinting 2. Trigger finger in diabetics: 2.1. 15 patien

Sponsors

Guy's & St Thomas' NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We have 3 separate cohorts in our study: 1. Cohort 1 ? Trigger Finger - all adults, either sex, aged 18 and over with single or multiple digit trigger finger disease. 2. Cohort 2 ? Trigger finger in diabetics with bilateral disease- all adults, either sex, aged 18 and over with symmetrical bilateral trigger finger(s) and a diagnosis of diabetes mellitus. 3. Cohort 3 ? De Quervains - all adults, either sex, aged 18 and over with De Quervains tenosynovitis.

Exclusion criteria

Exclusion criteria: Cohort 1: 1. Under 18 years 2. Those with a diagnosis of diabetes mellitus 3. All patients with a diagnosis of any form of cancer 4. Any patient >65 years old 5. With mini?mental state examination (MMSE) 65 years old 4. With MMSE 65 years old 3. With MMSE <21

Design outcomes

Primary

MeasureTime frame
Does high intensity laser therapy reduce symptoms of finger locking and pain in trigger finger disease (a condition where finger tendons can inflammed and become locked in a flexed/bent position facing the palm), and does it reduce pain and improve strength in de quervains disease (inflammed tendons of the thumb).

Secondary

MeasureTime frame
1. The number of laser treatments sufficient to treat trigger finger disease and de quervains 2. The number of complications prevented by treating patients with laser therapy versus splinting 3. The cost effectiveness of treating patients with laser therapy versus splinting

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026